drugset
drugset / Trial / NCT04139213

Medication Maintenance Therapy in Community Pharmacy Settings

NCT04139213 ↗

Phase 2/3 Unknown 250 enrolled Lifespan The Miriam Hospital · collabUniversity of Rhode Island · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to compare pharmacy-based medication assisted treatment (MAT) with usual care MAT for people with opioid use disorder.

Timeline

Start
2019-07-25
Primary completion
2022-09-30
Completion
2022-10-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Naltrexone Small molecule 25 mg Other
Background Naltrexone Small molecule 50 mg Other
Background Naltrexone Small molecule 380 mg Other
Background buprenorphine/naloxone Unknown 8 mg Other
Background buprenorphine/naloxone Unknown 24 mg Other

Indications

opiate dependence